These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33418839)

  • 1. B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 Diabetes.
    Felton JL; Conway H; Bonami RH
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33418839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes.
    Bass LE; Bonami RH
    Antibodies (Basel); 2024 Apr; 13(2):. PubMed ID: 38651407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy.
    Wang Q; Racine JJ; Ratiu JJ; Wang S; Ettinger R; Wasserfall C; Atkinson MA; Serreze DV
    J Immunol; 2017 Dec; 199(11):3757-3770. PubMed ID: 29055002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes.
    Linsley PS; Greenbaum CJ; Rosasco M; Presnell S; Herold KC; Dufort MJ
    Genes Immun; 2019 Apr; 20(4):293-307. PubMed ID: 29925930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes.
    Ratiu JJ; Racine JJ; Hasham MG; Wang Q; Branca JA; Chapman HD; Zhu J; Donghia N; Philip V; Schott WH; Wasserfall C; Atkinson MA; Mills KD; Leeth CM; Serreze DV
    J Immunol; 2017 Jun; 198(11):4255-4267. PubMed ID: 28461573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell Activation.
    Apley KD; Griffith AS; Downes GM; Ross P; Farrell MP; Kendall P; Berkland CJ
    Bioconjug Chem; 2023 Nov; 34(11):2077-2088. PubMed ID: 37883211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes.
    Puertas MC; Carrillo J; Pastor X; Ampudia RM; Planas R; Alba A; Bruno R; Pujol-Borrell R; Estanyol JM; Vives-Pi M; Verdaguer J
    J Immunol; 2007 May; 178(10):6533-9. PubMed ID: 17475883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
    Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
    J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes.
    Mignogna C; Maddaloni E; D'Onofrio L; Buzzetti R
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1209-1219. PubMed ID: 34936848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
    Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice.
    Tan Q; Tai N; Li Y; Pearson J; Pennetti S; Zhou Z; Wong FS; Wen L
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetes pathogenesis - Prevention???
    Krishna CS; Srikanta S
    Indian J Endocrinol Metab; 2015 Apr; 19(Suppl 1):S58-63. PubMed ID: 25941654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
    Boitard C
    Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN; Wei CH
    J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives.
    Wan X; Zaghouani H
    Immunotherapy; 2014; 6(2):155-64. PubMed ID: 24491089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
    Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
    Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.